Volume 13 (2015): Issue 1 (Jan 2015)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xiv
Oncology Research Program
Pages: xxiv–xxv
Meet the New JNCCN!
By: Margaret Tempero
Pages: 1
After Local Therapy for Esophageal Cancer, Should We Continue to Survey Patients and, If So, Why and How?
By: Jaffer A. Ajani
Pages: 2–3
The Birth of NCCN
By: Joseph V. Simone
Pages: 7
Cotreatment of Hairy Cell Leukemia and Melanoma With the BRAF Inhibitor Dabrafenib
By: James S. Blachly, Gerard Lozanski, David M. Lucas, Michael R. Grever, Kari Kendra, and Leslie A. Andritsos
Pages: 9–13
Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia
By: C. Cameron Yin, Nitin Jain, Meenakshi Mehrotra, Jianhua Zhagn, Alexei Protopopov, Zhuang Zuo, Naveen Pemmaraju, Courtney DiNardo, Cheryl Hirsch-Ginsberg, Sa A. Wang, L. Jeffrey Medeiros, Lynda Chin, Keyur P. Patel, Farhad Ravandi, Andrew Futreal, and Carlos E. Bueso-Ramos
Pages: 19–22
Lung Cancer Screening, Version 1.2015
By: Douglas E. Wood, Ella Kazerooni, Scott L. Baum, Mark T. Dransfield, George A. Eapen, David S. Ettinger, Lifang Hou, David M. Jackman, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Ann N.C. Leung, Samir S. Makani, Pierre P. Massion, Bryan F. Meyers, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Peter B. Sachs, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Stephen C. Yang, Kristina M. Gregory, and Miranda Hughes
Pages: 23–34
Effect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Population
By: Harrys A. Torres, Parag Mahale, Boris Blechacz, Ethan Miller, Ahmed Kaseb, H. Franklin Herlong, Nathan Fowler, Ying Jiang, Issam I. Raad, and Dimitrios P. Kontoyiannis
Pages: 41–50
Predictors of Guideline Treatment Nonadherence and the Impact on Survival in Patients With Colorectal Cancer
By: Robert B. Hines, Alina Barrett, Philip Twumasi-Ankrah, Dominique Broccoli, Kimberly K. Engelman, Joaquina Baranda, Elizabeth A. Ablah, Lisette Jacobson, Michelle Redmond, Wei Tu, and Tracie C. Collins
Pages: 51–60
Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States
By: Ayal A. Aizer, Xiangmei Gu, Ming-Hui Chen, Toni K. Choueiri, Neil E. Martin, Jason A. Efstathiou, Andrew S. Hyatt, Powell L. Graham, Quoc-Dien Trinh, Jim C. Hu, and Paul L. Nguyen
Pages: 61–68
Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer
By: Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea
Pages: 69–77
Neuroendocrine Tumors, Version 1.2015
By: Matthew H. Kulke, Manisha H. Shah, Al B. Benson III, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Lyska Emerson, Paul F. Engstrom, Paul Fanta, Thomas Giordano, Whitney S. Goldner, Thorvardur R. Halfdanarson, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff II, Christopher Lieu, Jeffrey F. Moley, Gitonga Munene, Venu G. Pillarisetty, Leonard Saltz, Julie Ann Sosa, Jonathan R. Strosberg, Jean-Nicolas Vauthey, Christopher Wolfgang, James C. Yao, Jennifer Burns, and Deborah Freedman-Cass
Pages: 78–108
Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors
By: Sujata Narayanan and Pamela L. Kunz
Pages: 109–117
Paving the Road to Clinical Trial Participation: Removing Road Blocks and Directing Patients Toward Novel Therapies
By: Andrea Wang-Gillam and Kristina Williams
Pages: 118–120
Management of Chemotherapy-Induced Neutropenia: Measuring Quality, Cost, and Value
By: Michaela A. Dinan, Bradford R. Hirsch, and Gary H. Lyman
Pages: e1–e7
  • Collapse
  • Expand